ISSN: 0975-0851
Statistical considerations in biosimilar assessment using biosimilarity index
In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation
View More »
Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report
Perspective
Bioequivalence in Food and Drug Administration and Drug Safety
DOI: 10.35248/0975-0851.24.16.585
Significance of Bioequivalency Clinical Trials and their Applications in Drug Development
DOI: 10.35248/0975-0851.24.16.586
Significance of Healthy Participants in Bioequivalence Research and the Development of Generic Pharmaceuticals
DOI: 10.35248/0975-0851.24.16.587
Commentary Article
Advancements in Bioequivalence Testing: Innovations and Technologies
DOI: 10.35248/0975-0851.24.16.588
Quality Assurance in the Clinical Conduct of Bioequivalence Studies
DOI: 10.35248/0975-0851.24.16.589
Drug Metabolism and Bioequivalence Importance in Antipsychotic Treatments
DOI: 10.35248/0975-0851.24.16.590
Opinion Article
The Importance of Bioequivalence in Anticancer Medications
DOI: 10.35248/0975-0851.24.16.591
Pharmacokinetic Variability and Bioequivalence in Antidiuretic Drugs
DOI: 10.35248/0975-0851.24.16.592
The Importance of Bioequivalence in the European Pharmaceutical Market
DOI: 10.35248/0975-0851.24.16.593
Short Communication
Bioequivalence Testing for Drugs with Complex Metabolism and Metabolic Variability
DOI: 10.35248/0975-0851.24.16.594